Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hassan Urges Incoming Congress To Sustain U.S. Biomedical Strength

Executive Summary

Schering-Plough CEO Fred Hassan is urging newly elected members of Congress to help preserve the strength of the U.S. biomedical industry in the face of rising foreign competition

You may also be interested in...



India Ready For Chemistry Outsourcing, Wyeth Says; Biology Remains In West

India is currently a viable option for simple chemistry outsourcing and offshoring; however, additional skill development is needed before medicinal chemistry and biology operations can be conducted there, speakers said at the Financial Times Global Pharmaceuticals & Biotechnology conference in London Sept. 18

FDA Opposes Enzi/Kennedy Drug Safety Bill; Action More Likely Through PDUFA

Pending drug safety legislation from Sens. Michael Enzi (R-Wyo.) and Edward Kennedy (D-Mass.) may do more harm than good, FDA implied in comments submitted to the Senate Health Committee

NEJM, JAMA Editorials Give Opposing Opinions Of Mandatory HPV Vaccination

Two of the leading medical journals are offering opposing viewpoints on mandatory human papilloma virus vaccination, with experts contributing perspective pieces that directly reflect the larger political and social division over the issue

Latest Headlines
See All
UsernamePublicRestriction

Register

PS047789

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel